{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:43:31Z","timestamp":1790279011689,"version":"4.1.0"},"reference-count":88,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>GH excess causes an increase in bone turnover, but the consequences in terms of skeletal fragility have long been uncertain due to the heterogeneity of studies dealing with this topic.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>We conducted a meta-analysis of studies examining the effects of acromegaly on bone turnover, bone mineral density (BMD), and fractures. Furthermore, we evaluated the effects of sex, gonadal status, and activity of disease on skeletal end-points in acromegaly.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data Sources:<\/jats:title>\n                  <jats:p>We conducted MEDLINE and EMBASE systematic searches up to December 31, 2013.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Study Eligibility Criteria:<\/jats:title>\n                  <jats:p>Studies conducted in patients with acromegaly and reporting at least one determinant of skeletal fragility.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data Extraction and Analysis:<\/jats:title>\n                  <jats:p>Study design, patient characteristics, interventions, and outcomes were independently extracted by two authors. We calculated the standardized mean difference (SMD) of bone turnover and BMD differences, whereas fractures were presented as relative frequencies in acromegaly and odds ratios between patients and controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Forty-one studies fulfilled eligibility criteria and were therefore selected for data extraction and analysis. A total of 1935 patients were included (eight to 206 per study). Acromegaly patients had higher bone formation (SMD, 1.49; 95% confidence interval [CI], 0.97\u20132.01; P &amp;lt; .0001) and bone resorption (SMD, 1.57; 95% CI, 1.03\u20132.10; P &amp;lt; .0001) as compared to control subjects, without significant differences in lumbar spine BMD. BMD at the femoral neck tended to be higher in acromegaly patients vs control subjects (SMD, 0.67; 95% CI, 0.07\u20131.27; P = .03). Patients with acromegaly had high frequency of vertebral fractures (odds ratio, 8.26; 95% CI, 2.91\u201323.39; P &amp;lt; .0001), in close relationship with male gender, hypogonadism, and active acromegaly.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Limitations:<\/jats:title>\n                  <jats:p>Limitations included heterogeneous study protocols with possible variability in the assessment of skeletal end-points.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>Skeletal fragility is an emerging complication of acromegaly.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2014-2937","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T18:38:38Z","timestamp":1415039918000},"page":"384-394","source":"Crossref","is-referenced-by-count":167,"title":["Bone Turnover, Bone Mineral Density, and Fracture Risk in Acromegaly: A Meta-Analysis"],"prefix":"10.1210","volume":"100","author":[{"given":"Gherardo","family":"Mazziotti","sequence":"first","affiliation":[{"name":"Endocrinology (G.M., F.M., V.S., A.G.), 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Biagioli","sequence":"additional","affiliation":[{"name":"Department of Oncology (E.B., I.F.), Instituto di Ricovero e Cura a Carattere Scientifico\u2013Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, 20156 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Maffezzoni","sequence":"additional","affiliation":[{"name":"Endocrinology (G.M., F.M., V.S., A.G.), 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Spinello","sequence":"additional","affiliation":[{"name":"Novartis Farma (M.S.), 21040 Origgio, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Serra","sequence":"additional","affiliation":[{"name":"Endocrinology (G.M., F.M., V.S., A.G.), 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Maroldi","sequence":"additional","affiliation":[{"name":"Radiology (R.M.), University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Floriani","sequence":"additional","affiliation":[{"name":"Department of Oncology (E.B., I.F.), Instituto di Ricovero e Cura a Carattere Scientifico\u2013Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, 20156 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giustina","sequence":"additional","affiliation":[{"name":"Endocrinology (G.M., F.M., V.S., A.G.), 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071614383427200_B1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","article-title":"Growth hormone, insulin-like growth factors, and the skeleton","volume":"29","author":"Giustina","year":"2008","journal-title":"Endocr Rev"},{"key":"2020071614383427200_B2","first-page":"18","article-title":"GH deficiency in the adult and bone","volume":"28","author":"Doga","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"2020071614383427200_B3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/er.2013-1071","article-title":"Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications","volume":"35","author":"Kamenick\u00fd","year":"2014","journal-title":"Endocr Rev"},{"key":"2020071614383427200_B4","first-page":"188","volume-title":"The Parathyroid Glands and Metabolic Bone Disease: Selected Studies","author":"Albright","year":"1948"},{"key":"2020071614383427200_B5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1210\/jcem-34-6-911","article-title":"The nature of the metabolic bone disorder in acromegaly","volume":"34","author":"Riggs","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614383427200_B6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1530\/acta.0.0970018","article-title":"Iliac crest bone mass and remodelling in acromegaly","volume":"97","author":"Halse","year":"1981","journal-title":"Acta Endocrinol"},{"key":"2020071614383427200_B7","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1172\/JCI110570","article-title":"Differential effects of endocrine dysfunction on the axial and the appendicular skeleton","volume":"69","author":"Seeman","year":"1982","journal-title":"J Clin Invest"},{"key":"2020071614383427200_B8","first-page":"457","article-title":"Bone density of the lumbar spine and femur in acromegaly [in German]","volume":"33","author":"H\u00fcbsch","year":"1993","journal-title":"Radiologe"},{"key":"2020071614383427200_B9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2265.2001.01280.x","article-title":"Bone metabolism and body composition in Japanese patients with active acromegaly","volume":"55","author":"Kaji","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614383427200_B10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.7326\/0003-4819-111-7-567","article-title":"Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism","volume":"111","author":"Diamond","year":"1989","journal-title":"Ann Intern Med"},{"key":"2020071614383427200_B11","first-page":"1452","article-title":"Biochemical assessment of bone formation and resorption in acromegaly","volume":"76","author":"Ezzat","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614383427200_B12","first-page":"1608","article-title":"Bone mineral density of the axial skeleton in acromegaly","volume":"33","author":"Ho","year":"1992","journal-title":"J Nucl Med"},{"key":"2020071614383427200_B13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jbmr.5650080410","article-title":"Bone mineral density and parameters of bone metabolism in patients with acromegaly","volume":"8","author":"Kotzmann","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2020071614383427200_B14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF01622293","article-title":"Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine","volume":"7","author":"Kayath","year":"1997","journal-title":"Osteoporos Int"},{"key":"2020071614383427200_B15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00198-003-1531-z","article-title":"Fracture risk is decreased in acromegaly\u2013a potential beneficial effect of growth hormone","volume":"15","author":"Vestergaard","year":"2004","journal-title":"Osteoporos Int"},{"key":"2020071614383427200_B16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2362.2002.00944.x","article-title":"Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly","volume":"32","author":"Ueland","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"2020071614383427200_B17","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1359\/JBMR.050603","article-title":"Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women","volume":"20","author":"Bonadonna","year":"2005","journal-title":"J Bone Miner Res"},{"key":"2020071614383427200_B18","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1210\/jc.2008-0791","article-title":"Prevalence of vertebral fractures in men with acromegaly","volume":"93","author":"Mazziotti","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614383427200_B19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2265.2008.03322.x","article-title":"Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study","volume":"70","author":"Battista","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614383427200_B20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/EJE-10-1005","article-title":"High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly","volume":"164","author":"Wassenaar","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2020071614383427200_B21","first-page":"37","article-title":"Prevalence of osteoporosis and vertebral fractures in acromegalic patients","volume":"8","author":"Padova","year":"2011","journal-title":"Clin Cases Miner Bone Metab"},{"key":"2020071614383427200_B22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jocd.2012.06.002","article-title":"Vertebral fracture assessment in acromegaly","volume":"16","author":"Madeira","year":"2013","journal-title":"J Clin Densitom"},{"key":"2020071614383427200_B23","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1210\/jc.2013-1460","article-title":"Vertebral fractures in patients with acromegaly: a 3-year prospective study","volume":"98","author":"Mazziotti","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614383427200_B24","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1210\/jc.2013-2695","article-title":"Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study","volume":"98","author":"Claessen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614383427200_B25","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/cen.12262","article-title":"FRAX score in acromegaly: does it tell the whole story?","volume":"80","author":"Brzana","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614383427200_B26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12020-011-9486-x","article-title":"Influence of diabetes mellitus on vertebral fractures in men with acromegaly","volume":"40","author":"Mazziotti","year":"2011","journal-title":"Endocrine"},{"key":"2020071614383427200_B27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12020-011-9570-2","article-title":"New understanding and treatments for osteoporosis","volume":"41","author":"Mazziotti","year":"2012","journal-title":"Endocrine"},{"key":"2020071614383427200_B28","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/BF03349164","article-title":"Diagnosis and treatment of acromegaly complications","volume":"26","author":"Giustina","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"2020071614383427200_B29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11102-012-0420-x","article-title":"A consensus on the diagnosis and treatment of acromegaly complications","volume":"16","author":"Melmed","year":"2013","journal-title":"Pituitary"},{"key":"2020071614383427200_B30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11102-011-0310-7","article-title":"Clinical, quality of life, and economic value of acromegaly disease control","volume":"14","author":"Ben-Shlomo","year":"2011","journal-title":"Pituitary"},{"key":"2020071614383427200_B31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos Int"},{"key":"2020071614383427200_B32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: an update","volume":"28","author":"DerSimonian","year":"2007","journal-title":"Contemp Clin Trials"},{"key":"2020071614383427200_B33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2020071614383427200_B34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0009-8981(79)90285-7","article-title":"Bone isoenzyme of serum alkaline phosphatase in acromegaly","volume":"93","author":"Stepan","year":"1979","journal-title":"Clin Chim Acta"},{"key":"2020071614383427200_B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000180625","article-title":"Normal calcitonin secretion in acromegaly","volume":"25","author":"Tabolli","year":"1987","journal-title":"Horm Res"},{"key":"2020071614383427200_B36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF02555167","article-title":"Correlation among plasma osteocalcin, growth hormone, and somatomedin C in acromegaly","volume":"43","author":"de la Piedra","year":"1988","journal-title":"Calcif Tissue Int"},{"key":"2020071614383427200_B37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0011-393X(05)80195-X","article-title":"Parathormone levels during treatment of acromegaly with octreotide: one year follow-up","volume":"53","author":"Legovini","year":"1993","journal-title":"Curr Ther Res"},{"key":"2020071614383427200_B38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF00571329","article-title":"Serum bone Gla protein as a marker of bone turnover in acromegaly","volume":"52","author":"Marazuela","year":"1993","journal-title":"Calcif Tissue Int"},{"key":"2020071614383427200_B39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-2007-1001672","article-title":"Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome","volume":"26","author":"Piovesan","year":"1994","journal-title":"Horm Metab Res"},{"key":"2020071614383427200_B40","first-page":"377","article-title":"Differential presentation of cortical and trabecular peripheral bone mineral density in acromegaly","volume":"1","author":"Jockenh\u00f6vel","year":"1996","journal-title":"Eur J Med Res"},{"key":"2020071614383427200_B41","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1359\/jbmr.1997.12.10.1729","article-title":"Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients","volume":"12","author":"Scillitani","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2020071614383427200_B42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2265.1998.00349.x","article-title":"Gonadal status is an important determinant of bone density in acromegaly","volume":"48","author":"Lesse","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614383427200_B43","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/BF03350799","article-title":"Bone mineral density and circulating cytokines in patients with acromegaly","volume":"21","author":"Longobardi","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"2020071614383427200_B44","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S1076-6332(00)80573-5","article-title":"Axial bone mineral density in patients with acromegaly","volume":"7","author":"Bolanowski","year":"2000","journal-title":"Acad Radiol"},{"key":"2020071614383427200_B45","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1530\/eje.0.1450685","article-title":"Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess\u2013possible role in bone homeostasis","volume":"145","author":"Ueland","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"2020071614383427200_B46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s001980200009","article-title":"Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone","volume":"13","author":"Minisola","year":"2002","journal-title":"Osteoporos Int"},{"key":"2020071614383427200_B47","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1210\/jc.2003-030772","article-title":"Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal","volume":"88","author":"Parkinson","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614383427200_B48","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1365-2265.2003.01777.x","article-title":"Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status","volume":"58","author":"Scillitani","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614383427200_B49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s007740300015","article-title":"Various risks of osteoporosis in patients with pituitary adenomas","volume":"21","author":"Matsuyama","year":"2003","journal-title":"J Bone Miner Metab"},{"key":"2020071614383427200_B50","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-2004-820913","article-title":"Factors associated with bone metabolism in acromegalic patients: hypogonadism and female gender","volume":"112","author":"T\u00fct\u00fcnc\u00fc","year":"2004","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2020071614383427200_B51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/eje.1.01820","article-title":"Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly","volume":"152","author":"Biermasz","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2020071614383427200_B52","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00774-005-0649-9","article-title":"Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function","volume":"24","author":"Bolanowski","year":"2006","journal-title":"J Bone Miner Metab"},{"key":"2020071614383427200_B53","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1530\/eje.1.02285","article-title":"Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients","volume":"155","author":"Ueland","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2020071614383427200_B54","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1210\/jc.2005-1602","article-title":"Effect of active acromegaly and its treatment on parathyroid circadian rhythmicity and parathyroid target-organ sensitivity","volume":"91","author":"White","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614383427200_B55","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jocd.2007.03.103","article-title":"Bone properties in patients with acromegaly: quantitative ultrasound of the heel","volume":"10","author":"Kastelan","year":"2007","journal-title":"J Clin Densitom"},{"key":"2020071614383427200_B56","first-page":"621","article-title":"In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender","volume":"28","author":"Zgliczynski","year":"2007","journal-title":"Neuro Endocrinol Lett"},{"key":"2020071614383427200_B57","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1530\/EJE-08-0449","article-title":"Gender dimorphism in body composition abnormalities in acromegaly: males are more affected than females","volume":"159","author":"Sucunza","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"2020071614383427200_B58","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1210\/jc.2009-0474","article-title":"A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly","volume":"94","author":"Sucunza","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614383427200_B59","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00198-009-1165-x","article-title":"Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly","volume":"21","author":"Madeira","year":"2010","journal-title":"Osteoporos Int"},{"key":"2020071614383427200_B60","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1210\/jc.2012-4073","article-title":"Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography","volume":"98","author":"Madeira","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614383427200_B61","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra067395","article-title":"Mechanisms of anabolic therapies for osteoporosis","volume":"357","author":"Canalis","year":"2007","journal-title":"N Engl J Med"},{"key":"2020071614383427200_B62","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.060112","article-title":"Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy","volume":"21","author":"Mazziotti","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2020071614383427200_B63","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2013-3921","article-title":"Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis","volume":"99","author":"Barake","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614383427200_B64","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1210\/endo.137.11.8895324","article-title":"Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-\u03b1 production","volume":"137","author":"Renier","year":"1996","journal-title":"Endocrinology"},{"key":"2020071614383427200_B65","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1096-6374(03)00034-0","article-title":"Growth hormone enhances proinflammatory cytokine production by monocytes in whole blood","volume":"13","author":"Uronen-Hansson","year":"2003","journal-title":"Growth Horm IGF Res"},{"key":"2020071614383427200_B66","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12020-012-9770-4","article-title":"Is every joint symptom related to acromegaly?","volume":"43","author":"\u00d6r\u00fck","year":"2013","journal-title":"Endocrine"},{"key":"2020071614383427200_B67","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12020-012-9781-1","article-title":"Acromegalic arthropathy: current perspectives","volume":"43","author":"Romijn","year":"2013","journal-title":"Endocrine"},{"key":"2020071614383427200_B68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jbmr.5650070214","article-title":"Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985\u20131989","volume":"7","author":"Cooper","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2020071614383427200_B69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12020-012-9691-2","article-title":"New advances in imaging osteoporosis and its complications","volume":"42","author":"Griffith","year":"2012","journal-title":"Endocrine"},{"key":"2020071614383427200_B70","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1359\/jbmr.2003.18.7.1254","article-title":"Association between vertebral fracture and increased mortality in osteoporotic patients","volume":"18","author":"Jalava","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2020071614383427200_B71","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1001\/jama.298.23.2761","article-title":"Long-term risk of incident vertebral fractures","volume":"298","author":"Cauley","year":"2007","journal-title":"JAMA"},{"key":"2020071614383427200_B72","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1359\/jbmr.2000.15.7.1384","article-title":"Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures","volume":"15","author":"Oleksik","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2020071614383427200_B73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-2265.2001.01189.x","article-title":"The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients","volume":"54","author":"Murray","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614383427200_B74","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ultrasmedbio.2005.10.003","article-title":"Quantitative ultrasound at the hand phalanges in patients with acromegaly","volume":"32","author":"Bolanowski","year":"2006","journal-title":"Ultrasound Med Biol"},{"key":"2020071614383427200_B75","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12020-014-0280-4","article-title":"Utility of the trabecular bone score (TBS) in secondary osteoporosis","volume":"47","author":"Ulivieri","year":"2014","journal-title":"Endocrine"},{"key":"2020071614383427200_B76","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1210\/jc.2006-2547","article-title":"Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis","volume":"92","author":"Maison","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614383427200_B77","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1210\/jc.2008-2332","article-title":"Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies","volume":"94","author":"Mazziotti","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614383427200_B78","doi-asserted-by":"crossref","first-page":"e36411","DOI":"10.1371\/journal.pone.0036411","article-title":"Meta-analysis on the effects of octreotide on tumor mass in acromegaly","volume":"7","author":"Giustina","year":"2012","journal-title":"PLoS One"},{"key":"2020071614383427200_B79","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1210\/jc.2013-3757","article-title":"Acromegaly clinical trial methodology impact on reported biochemical efficacy rates of somatostatin receptor ligand treatments: a meta-analysis","volume":"99","author":"Carmichael","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614383427200_B80","first-page":"526","article-title":"Criteria for cure of acromegaly: a consensus statement","volume":"85","author":"Giustina","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614383427200_B81","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1210\/jc.2009-2670","article-title":"A consensus on criteria for cure of acromegaly","volume":"95","author":"Giustina","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614383427200_B82","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrendo.2014.21","article-title":"Expert consensus document: a consensus on the medical treatment of acromegaly","volume":"10","author":"Giustina","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"2020071614383427200_B83","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Stat Med"},{"key":"2020071614383427200_B84","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bone.2009.06.006","article-title":"Vertebral fractures in males with type 2 diabetes treated with rosiglitazone","volume":"45","author":"Mancini","year":"2009","journal-title":"Bone"},{"key":"2020071614383427200_B85","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.amjmed.2010.02.028","article-title":"Drug-induced osteoporosis: mechanisms and clinical implications","volume":"123","author":"Mazziotti","year":"2010","journal-title":"Am J Med"},{"key":"2020071614383427200_B86","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1517\/14656566.2013.847090","article-title":"Octreotide for acromegaly treatment: a reappraisal","volume":"14","author":"Giustina","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"2020071614383427200_B87","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12020-014-0206-1","article-title":"Cabergoline treatment in acromegaly: pros","volume":"46","author":"Marazuela","year":"2014","journal-title":"Endocrine"},{"key":"2020071614383427200_B88","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s40618-014-0146-x","article-title":"Use of pegvisomant in acromegaly. An Italian Society of Endocrinology guideline","volume":"37","author":"Giustina","year":"2014","journal-title":"J Endocrinol Invest"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/100\/2\/384\/10854203\/jcem0384.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/100\/2\/384\/10854203\/jcem0384.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T02:22:57Z","timestamp":1594952577000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/100\/2\/384\/2813197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,1]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2014-2937","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,1]]}}}